跳至主要内容
临床试验/EUCTR2018-003533-15-DK
EUCTR2018-003533-15-DK进行中(未招募)1 期

Clinical and pathophysiological aspects of visualization of metabolic flux in the failing human heart using hyperpolarized [1-13C]-pyruvate cardiac magnetic resonance

Department of Cardiology, Aarhus University Hospital0 个研究点目标入组 60 人开始时间: 2018年11月1日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Dilated Cardiomyopathy
  • > 18 years of age.
  • Diagnosis of Dilated Cardiomyopathy (DCM)
  • Left ventricular Ejection Fraction (LVEF) of 10 – 45 %
  • Adequate hematologic and organ function, i.e.
  • ANC at least 1.500/uL
  • Platelet count >100/uL
  • Se bilirubin <1.5 UNL
  • ASAT, ALAT and AP up to 2.5 x UNL
  • Se creatinine up to 1.5 x UNL or creatinine clearance at least 30 ml/min
  • INR and aPTT at most 1.5 x UNL, except for patients on AK treatment
  • Women who are not postmenopausal or surgically sterile must have a negative serum or urine pregnancy test performed at time of inclusion in the study. Safe and highly effective contraception must be used throughout the study meaning either hormonal anti-conception or an anti-fertility intrauterine device. If the partner is non fertile or the patient has no sexual activities, this is also accepted.
  • Danish speaking
  • Able and willing to comply after informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • Not able or willing to receive heart failure therapy
  • Patients not willing to participate
  • Uncontrolled serious medical condition, such as uncontrolled heart
  • disease, uncontrolled diabetes, intestinal obstruction, uncontrolled
  • hypertension, or recent cerebral ischemia
  • Receiving more than 50% of taget dose of ACE-inhibitor and
  • betablockers before inclusion
  • Previous heart surgery including PCI
  • Estimated Glomerular Filtration Rate (eGFR) <30 mL/min
  • Diabetes Mellitus
  • Intolerance to Pyruvate

研究者

发起方
Department of Cardiology, Aarhus University Hospital

相似试验